Table 2. Comparison of patients’ total and individual organ SOFA scores in non-serious group and serious group at hospital presentation.
| Variable | Serious group (n=147) | Non-serious group (n=152) | P value |
|---|---|---|---|
| SOFA total | 5 [2–9] | 0 [0–1] | <0.001 |
| SOFA classification, n (%) | <0.001 | ||
| ≥2 | 113 (76.87) | 34 (22.37) | |
| <2 | 34 (23.13) | 118 (77.63) | |
| SOFA score | |||
| Respiration | 1 [0–3] | 0 [0–0] | <0.001 |
| Coagulation | 0 [0–0] | 0 [0–0] | 0.018 |
| Liver | 0 [0–0] | 0 [0–0] | 0.109 |
| Cardiovascular | 0 [0–1] | 0 [0–0] | <0.001 |
| CNS | 0 [0–0] | 0 [0–0] | <0.001 |
| Renal | 0 [0–1] | 0 [0–0] | <0.001 |
Data are presented as number (percentage) or median [interquartile range]. Non-serious group: patients with mild and moderate SARS-Cov-2 infection; Serious group: patients with severe and critical SARS-Cov-2 infection. SOFA, Sequential Organ Failure Assessment; CNS, central nervous system; SARS-Cov-2, severe acute respiratory syndrome coronavirus 2.